- Home
- PGEN vs BNY Comparison
PGEN vs BNY Comparison
Compare PGEN & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- BNY
- Stock Information
- Founded
- PGEN 1998
- BNY 2001
- Country
- PGEN United States
- BNY United States
- Employees
- PGEN N/A
- BNY N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- BNY Trusts Except Educational Religious and Charitable
- Sector
- PGEN Health Care
- BNY Finance
- Exchange
- PGEN Nasdaq
- BNY Nasdaq
- Market Cap
- PGEN 292.6M
- BNY 254.2M
- IPO Year
- PGEN N/A
- BNY N/A
- Fundamental
- Price
- PGEN $0.90
- BNY $10.48
- Analyst Decision
- PGEN Buy
- BNY
- Analyst Count
- PGEN 5
- BNY 0
- Target Price
- PGEN $7.00
- BNY N/A
- AVG Volume (30 Days)
- PGEN 858.0K
- BNY 52.7K
- Earning Date
- PGEN 11-14-2024
- BNY 01-01-0001
- Dividend Yield
- PGEN N/A
- BNY 3.93%
- EPS Growth
- PGEN N/A
- BNY N/A
- EPS
- PGEN N/A
- BNY N/A
- Revenue
- PGEN $3,963,000.00
- BNY N/A
- Revenue This Year
- PGEN N/A
- BNY N/A
- Revenue Next Year
- PGEN $211.35
- BNY N/A
- P/E Ratio
- PGEN N/A
- BNY N/A
- Revenue Growth
- PGEN N/A
- BNY N/A
- 52 Week Low
- PGEN $0.77
- BNY $8.60
- 52 Week High
- PGEN $1.93
- BNY $10.80
- Technical
- Relative Strength Index (RSI)
- PGEN 52.02
- BNY 37.48
- Support Level
- PGEN $0.77
- BNY $10.47
- Resistance Level
- PGEN $1.05
- BNY $10.77
- Average True Range (ATR)
- PGEN 0.07
- BNY 0.09
- MACD
- PGEN -0.00
- BNY -0.01
- Stochastic Oscillator
- PGEN 47.46
- BNY 3.33
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr has an investment objective to provide current income exempt from regular U.S. federal income tax and New York State and New York City personal income taxes. The Trust seeks to achieve its investment objective by investing primarily in municipal bonds exempt from U.S. federal income taxes and New York State and New York City personal income taxes.